ASAT

Login
  • About ASAT
  • About Autism
  • Intervention
  • Conferences
  • Resources
  • Media Watch
  • Text size:
  • S
  • M
  • L
  • XL
  • High Contrast:
  • S
  • M
  • L
  • XL
Intervention Autism Treatment... Summaries of Sci... Secretin
  • Intervention
  • Autism treatments: Descriptions and research summaries
  • Video Examples
  • Description of Service Providers
  • Making Sense of Autism Treatments: Weighing the evidence
  • Recommendations of expert panels & government task forces

Secretin

Description: Administration of secretin, a hormone involved in digestion. This hormone (which can be natural or synthetic) is administered intravenously, orally or transdermally.

Research Summary: Fourteen large, well-designed studies with many hundreds of individuals with autism spectrum disorders have shown that secretin is ineffective (Williams, Wray, & Wheeler, 2005). Secretin is an inappropriate treatment for individuals with autism spectrum disorders.

Recommendations: Secretin is not a useful intervention for individuals with autism spectrum disorders.

Selected References:

Systematic reviews of scientific studies:

  • Williams, K. W., Wray, J. J., & Wheeler, D. M. (2005). Intravenous secretin for autism spectrum disorder. The Cochrane Database of Systematic Reviews, 4.
Winter Newsletter
Now Available
Newsletter
Sign up now

Site Map • Privacy Policy • Contact Us

P.O. Box 188, Crosswicks, NJ 08515-0188 • info@asatonline.org

© Association for Science in Autism Treatment. This article is for personal use only. This article may not be republished or reprinted without advance permission from ASAT. For reprint permission please contact reprints@asatonline.org